Literature DB >> 20884258

Evaluation of the influence of polymorphic variants CYP1A1 2B, CYP1B1 2, CYP3A4 1B, GSTM1 0, and GSTT1 0 in prostate cancer.

Iara S Rodrigues1, Hellen Kuasne, Roberta Losi-Guembarovski, Paulo E Fuganti, Emerson P Gregório, Marina O Kishima, Kazuhiro Ito, Marco A de Freitas Rodrigues, Ilce M de Syllos Cólus.   

Abstract

BACKGROUND/
OBJECTIVE: Genetic polymorphisms in cytochrome P-450 (CYPs) and glutathione S-transferase (GSTs) genes can influence the appearance of tumors by the formation of new enzymes with altered activities. In the present study, 5 polymorphic variants were examined in 154 patients with prostate carcinoma and in 154 controls.
MATERIALS AND METHODS: DNA analysis was carried out through PCR-based methods. The statistical methods used were odds ratio and confidence interval (95% CI), χ(2), Fisher, and Mann-Whitney.
RESULTS: The study showed absence of association for CYP1A1 2B, CYP1B1 2, GSTM1 0, and GSTT1 0. The statistical analysis implied a positive association of variant CYP3A4 1B for prostate cancer. The combined analysis of CYP1A1 2B, CYP1B1 2, and CYP3A4 1B genotypes showed positive association. The analysis of histopathologic parameters detected statistically significant differences for Gleason score and biochemistry recurrence risk. The presence of the GSTT1 0 genotype in red meat consumers increased the risk for this disease.
CONCLUSION: Some polymorphic variants analyzed can influence the development and the progression of prostate cancer.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20884258     DOI: 10.1016/j.urolonc.2010.01.009

Source DB:  PubMed          Journal:  Urol Oncol        ISSN: 1078-1439            Impact factor:   3.498


  17 in total

1.  Influence of CYP3A4 genotypes in the outcome of serous ovarian cancer patients treated with first-line chemotherapy: implication of a CYP3A4 activity profile.

Authors:  Joana Assis; Deolinda Pereira; Mónica Gomes; Dânia Marques; Inês Marques; Augusto Nogueira; Raquel Catarino; Rui Medeiros
Journal:  Int J Clin Exp Med       Date:  2013-08-01

2.  Association between the CYP1B1 polymorphisms and risk of cancer: a meta-analysis.

Authors:  Jie-Ying Liu; Yu Yang; Zhi-Zhong Liu; Jian-Jun Xie; Ya-Ping Du; Wei Wang
Journal:  Mol Genet Genomics       Date:  2014-12-05       Impact factor: 3.291

3.  Characterization of CYP1A2, CYP2C19, CYP3A4 and CYP3A5 polymorphisms in South Brazilians.

Authors:  Fabiana B Kohlrausch; Ángel Carracedo; Mara H Hutz
Journal:  Mol Biol Rep       Date:  2014-01-18       Impact factor: 2.316

4.  Association between the CYP3A4 and CYP3A5 polymorphisms and cancer risk: a meta-analysis and meta-regression.

Authors:  Xiao-Feng He; Zhi-Zhong Liu; Jian-Jun Xie; Wei Wang; Ya-Ping Du; Yu Chen; Wu Wei
Journal:  Tumour Biol       Date:  2014-07-04

5.  Quantitative synthesis of the association between the cytochrome P450 1A1 Ile462Val polymorphism and prostate cancer risk.

Authors:  Guangye Han; Yanjuan Ma; Pei Liu; Xiaoxia Wei; Xinjun Zhang; Feng Zhu
Journal:  Tumour Biol       Date:  2013-02-06

6.  Association of GSTT1 gene polymorphisms with the risk of prostate cancer: an updating meta-analysis.

Authors:  Jihong Wang; Yuemin Xu; Qiang Fu; Jianjun Yu; Zhong Chen; Zhangshun Liu; Chao Li; Hui Guo; Mingkai Xie
Journal:  Tumour Biol       Date:  2013-03-02

7.  Association of CYP1A1 polymorphisms with prostate cancer risk: an updated meta-analysis.

Authors:  Huawen Li; Deqian Xiao; Liren Hu; Taiping He
Journal:  Mol Biol Rep       Date:  2012-10-14       Impact factor: 2.316

8.  Polymorphisms in CYP17 and CYP3A4 and prostate cancer in men of African descent.

Authors:  Emanuela Taioli; Vestra Sears; Alexis Watson; Rafael E Flores-Obando; Maria D Jackson; Flora A Ukoli; Ilce M de Syllos Cólus; Pedro Fernandez; Norma McFarlane-Anderson; Elaine A Ostrander; Iara S Rodrigues; Janet L Stanford; Jack A Taylor; Marshall Tulloch-Reid; Camille C R Ragin
Journal:  Prostate       Date:  2012-11-05       Impact factor: 4.104

Review 9.  CYP1A1 and GSTP1 gene variations in breast cancer: a systematic review and case-control study.

Authors:  Sumaira Akhtar; Ishrat Mahjabeen; Zertashia Akram; Mahmood Akhtar Kayani
Journal:  Fam Cancer       Date:  2016-04       Impact factor: 2.375

10.  Significant association of Glutathione S-transferase T1 null genotype with prostate cancer risk: a meta-analysis of 26,393 subjects.

Authors:  Qing Yang; Jun Du; Xin Yao
Journal:  PLoS One       Date:  2013-01-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.